[vc_row][vc_column width=”1/6″][/vc_column][vc_column offset=”vc_col-lg-8 vc_col-md-8″][vc_custom_heading text=”Fellows of IC-OS” font_container=”tag:h2|text_align:center|color:%2317509e” use_theme_fonts=”yes” el_class=”cs_head”][vc_custom_heading text=”Fellowship is one of the most distinguished designations that ICOS offers its members. One’s vital participation and leadership in the cardio-oncology community are recognized by this honor. Fellows are those who have made exceptional contributions to our mission of advancing the cardiovascular care of cancer patients and survivors.” font_container=”tag:h2|font_size:18px|text_align:center|line_height:32px” use_theme_fonts=”yes”][/vc_column][vc_column width=”1/6″][/vc_column][vc_column][vc_separator color=”custom” border_width=”2″ accent_color=”#dd3333″ el_class=”container” css=”.vc_custom_1566191468918{margin-top: 20px !important;}”][/vc_column][/vc_row][vc_row el_class=”section-padding leadership container” css=”.vc_custom_1565948487582{background-color: #f9f9f9 !important;}”][vc_column][vc_row_inner][vc_column_inner el_class=”section-title”][la_heading title=”Meet Our Fellows”][/la_heading][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12422″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Anita M. Arnold, DO, FACC , F-ICOS, MBA
Dr. Arnold is a graduate of the NY College of Osteopathic Medicine and subsequently completed her internal medicine residency at the Bryn Mawr Hospital in Philadelphia where she was the chief resident, then completed 4 years of Cardiology/Interventional Cardiology at the Cleveland Clinic in Ohio. She practiced most of her career in Milwaukee, Wisconsin where she was the medical director of the Cardiovascular Research Foundation, as well as a practicing interventionist. Time and weather eventually brought her to Florida, where she worked part time at USF working with the Cardiology Fellows while finishing an MBA program at the George Washington University in DC.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Michelle Weisfelner Bloom, MD
Dr. Bloom, a faculty cardiologist and Associate Clinical Professor of Medicine at Stony Brook University Medical Center, is board certified in Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology, and Cardio-Oncology. Her specialties include heart failure, complex valvular and structural heart disease, genetic cardiomyopathies, investigational medicines and devices, mechanical device therapies to treat advanced heart disease, and Cardio-Oncology.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”1014594″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12432″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Joseph R. Carver, MD, FACC
Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program. From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Dr. Daniel Cehic
Dr. Cehic is a cardiologist based in Adelaide, Australia. He trained at the University of Adelaide, Royal Adelaide Hospital and John Radcliffe Hospital in Oxford, England subspecialising in
Electrophysiology. He returned to Australia in 1997 and joined Adelaide Cardiology and became a Senior Visiting Cardiologist at the Royal Adelaide Hospital where he remained until 2008, leaving to take up full time private practice with what is now GenesisCare. He became the Chief Medical Officer
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”13960″ img_size=”medium” alignment=”right”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” el_id=”Susan-Dent”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″ css=”.vc_custom_1569481080467{margin-bottom: 50px !important;}”][vc_single_image image=”12446″ img_size=”medium”][/vc_column_inner][vc_column_inner width=”1/2″ el_id=”Susan”][vc_column_text el_id=”steve”]
Susan Dent, MD
Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff medical oncologist at the Northwestern Ontario Cancer Center in Thunder Bay, Ontario.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Michael Fradley, MD
Dr. Michael Fradley is an Associate Professor of Clinical Medicine in the Division of Cardiology at the Perelman School of Medicine at the University of Pennsylvania and serves as the medical director of the Penn Medicine Cardio-Oncology program. He earned his B.S at Yale University and his MD degree at the Johns Hopkins University School of Medicine.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12448″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12453″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Dr Kalliopi Keramida (MD, PhD, FESC, FHFA, FICOS)
Dr Kalliopi Keramida (MD, PhD, FESC, FHFA, FICOS) is a consultant cardiologist at General Anti-Cancer, Oncological Hospital Agios Savvas, Athens, Greece. She is board certified in Cardio-Oncology by International Cardio-Oncology Society (ICOS) (2020) and in Heart Failure (ESC/HFA) (2016).
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Anuradha Kolluru MD, FACC, FASE, FASNC, RPVI, FICOS
Dr Kolluru is a Board-certified practicing cardiologist with special interests in cardiac imaging and cardio-oncology in USA. She initially started cardio-oncology practice in Decatur, Illinois with large private oncologist group and worked for 8 years before moving to Seattle, Washington in 2020. She is currently working with Virginia Mason Franciscan Health system in Seattle providing cardiovascular care and developing cardio-oncology program.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”1014480″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1626177135230{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12455″ img_size=”medium”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Daniel Lenihan, MD, FACC, FESC
I have been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. My current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Teresa Lopez-Fernandez, MD
University Hospital La Paz, Madrid, Spain
Teresa López-Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain. She is specializes in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society)
[/vc_column_text][vc_column_text]
[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”9593″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12458″ img_size=”medium”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Joshua Mitchell, MD, MSCI
Joshua Mitchell, MD, MSCI is an Assistant Professor of Medicine and Director of the Cardio-Oncology Fellowship at the Cardio-Oncology Center of Excellence, Washington University School of Medicine in St. Louis. Prior to coming to Washington University in 2015, he served 11 years in the US Army, deploying with the 82nd Airborne Division and the 75th Ranger Regiment, earning two Bronze Start Medals, and reaching the rank of Major.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Charles Porter, MD
Charles Porter MD established the Cardio-oncology program for the University of Kansas Cancer at the University of Kansas Medical Center in 2007. He was designated as the inaugural American Vice-President of IC-OS in 2009. He has overseen the growth of the KUMC cardio-oncology program and continues to expand its collaboration with a broad array of oncologists in patient care and research.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12460″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12999″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Dr Arjun K Ghosh MBBS, MSc, PhD, FHEA, FESC, FACC, FRCP, FICOS
Dr Arjun Ghosh is a consultant cardiologist at Barts Heart Centre and University College London Hospital and runs the cardio-oncology programme at UCLH. He helped establish the UK’s first cardio-oncology course as well as the first pan-European cardio-oncology course and was joint first-author of the UK’s first cardio-oncology guidelines. Alongside educational activities, Arjun is involved in research in emerging cardiotoxcities and is also the co-host of the ICOS podcast.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Avirup Guha, MBBS, MPH, FACC, FICOS, RPVI
Dr. Guha is a Director of Cardio-Oncology, Cardio-Oncology Program, Georgia Cancer Center, Assistant Professor of Medicine, Division of Cardiovascular Disease, Augusta University, Augusta, GA, USA
1410 Laney Walker Blvd, CN 5313
Augusta, GA 30912
Twitter – @avirupguha
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”13480″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”13988″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Vijay Rao, MD, PhD
Dr. Rao completed his MD and PhD at the Medical University of South Carolina, Internal Medicine residency at Duke University Medical Center, followed by Cardiology fellowship at the University of California, San Francisco. He is the Director of the CardioOncology, Heart Failure, and Anticoagulation clinics at Franciscan Health in Indianapolis, Indiana.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Stuart D Rosen MA MD FRCP FESC FACC FHFA
Professor Stuart Rosen is Consultant Cardiologist at the Royal Brompton and London Northwest Hospitals and Professor of Practice (Cardiology) in the National Heart and Lung Institute, Imperial College and Honorary Adjunct Professor of Cardiovascular Medicine, King’s College, London. He received his medical undergraduate education at Pembroke College, Cambridge and at Charing Cross and Westminster Medical School. His specialist cardiology training was at Charing Cross, Hammersmith and St Mary’s Hospitals and he also spent several years in cardiovascular research, funded by the Medical Research Council and the British Heart Foundation.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”14109″ img_size=”medium” alignment=”right”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”13059″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Gagan Sahni MBBS, MD, FACC, FACP, FIC-OS
Dr. Sahni is currently Associate Professor of Medicine and Cardiovascular diseases at Mount Sinai Hospital, New York. She established the first Cardio-Oncology program at Mount Sinai Cardiovascular Institute, where she has been the Director of Cardio-Oncology and Inpatient Cardiology Consult services since 2014.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Sebastian Szmit M.D., Ph.D.
Associate Professor of Medicine
Sebastian Szmit graduated from the Military Medical Academy in Poland. He began cardio-
oncology activities in 2006 working for the Department of Oncology of the Military Institute of Medicine. He was appointed the executive editor of the Task Force of National Consultants in Cardiology and Clinical Oncology, and developed the first two Polish Recommendations on cardiovascular safety of patients with breast cancer (published in 2010) and lung cancer (published in 2012).
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12462″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”1014589″ img_size=”medium” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Tushar Tarun, MD, FACC, FIC-OS
Dr.Tarun is a non-invasive cardiologist at University of Arkansas for Medical Sciences. His interests include multi-modality cardiac imaging including Echocardiography, Cardiac CT, Cardiac MRI and Nuclear Cardiology. Dr Tarun takes care of cardio-oncology patients from all across the state that visit for their cancer and myeloma care at the renowned cancer center at University of Arkansas for Medical Sciences in Little Rock AR.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”container” css=”.vc_custom_1569481162948{margin-bottom: 50px !important;}”][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]
Dr. Kathleen Zhang
Dr. Zhang completed medical school and Internal Medicine residency at the University of Pennsylvania, followed by fellowships in Cardiology and Cardio-Oncology at Washington University in St. Louis. She specializes in the cardiovascular care of patients with cancer as well as cardiac amyloidosis at Washington University in St. Louis.
[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_single_image image=”12508″ img_size=”medium” alignment=”right” css_animation=”none”][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_column][vc_column][/vc_column][/vc_row][vc_row el_id=”exampleModalLong” el_class=”modal fade”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Dr. Eric Harrison MD
Dr Harrison curates a high resolution three dimensional heart imaging database (coronary computed tomography angiogram or CCTA) of 5,000 cases and created the Sherlock Program for predicting cardiac prognosis based on plaque morphology, composition, and function to predict cardiac events. He started the company PrivaCors to develop this concept nationally with artificial intelligence. PrivaCors was chosen by IBM Watson Healthcare to join their 24 company collaborative to implement AI in medical imaging and EKGs. He co-founded the International Cardio-Oncology Society a 501 (3) (c) and promoted our Global International Meeting in Tampa last year and Brazil this year. He founded Cardio-Orthopaedics, a new subspecialty of cardiology to contain the cardiac risk of orthopaedic Total Joint Arthroplasty (TJA) surgery. This program in collaboration with Florida Orthopaedic Institution has resulted in presentation at the International Society for Technology in Arthroplasty (ISTA) in London last year and in Toronto this year.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_id=”Daniel” el_class=”modal fade”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Daniel Lenihan, MD, FACC, FESC
I have been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. My current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis.
I am the Principal Investigator of the PROTECT study looking at cardiac safety in patients Undergoing proteasome inhibitor treatment for relapsed multiple myeloma and the recently completed PREDICT study, a large multicenter prospective study examining the role of cardiac biomarkers for the detection of cardiotoxicity during anthracycline based therapy. In addition, I am intimately involved in the latest treatment trials for cardiac amyloidosis.
I recently moved to Washington University in St Louis to enhance and expand the Cardio-Oncology Center of Excellence. I am at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continue to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. I am the current President of the International Cardio-Oncology Society (ICOS), www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Joseph”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Joseph R. Carver, MD
Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program.From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients. He is one of the Founding Editors of Cardio-oncology Journal. He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the clinical director of the Penn Cardio-oncology Center of Excellence and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He is one of the Founding Editors of Cardio-oncology Journal. He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the clinical director of the Penn Cardio-oncology Center of Excellence and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Anita”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Anita M. Arnold, DO, FACC , F-ICOS, MBA
Dr. Arnold is a graduate of the NY College of Osteopathic Medicine and subsequently completed her internal medicine residency at the Bryn Mawr Hospital in Philadelphia where she was the chief resident, then completed 4 years of Cardiology/Interventional Cardiology at the Cleveland Clinic in Ohio. She practiced most of her career in Milwaukee, Wisconsin where she was the medical director of the Cardiovascular Research Foundation, as well as a practicing interventionist. Time and weather eventually brought her to Florida, where she worked part time at USF working with the Cardiology Fellows while finishing an MBA program at the George Washington University in DC.
Her interest in Cardio-Oncology started while at USF, and she came to Fort Myers to start a program and advance the field. She has been one of the leaders in the field: on the American College of Cardiology Council for Cardio-Oncology, and chair of the Advocacy working group for several years. She is on the Board of Directors for the International Cardio-Oncology Society and chairs their education committee. She is Certified in Cardio-Oncology and is a Section editor for the Journal of Cardio-Oncology and a reviewer for JACC Cardio-Oncology and the American Heart Journal.
On a personal note, she is married to Matthew Mick, MD whom she met at the Cleveland Clinic, and they have a rescue dog named “Lucky”. Her charitable interests are Habitat for Humanity, The Humane Society, No Child Hungry and Sowhope an international charity for impoverished women.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Arjunk”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Dr Arjun K Ghosh MBBS, MSc, PhD, FHEA, FESC, FACC, FRCP, FICOS
Dr Arjun Ghosh is a consultant cardiologist at Barts Heart Centre and University College London Hospital and runs the cardio-oncology programme at UCLH. He helped establish the UK’s first cardio-oncology course as well as the first pan-European cardio-oncology course and was joint first-author of the UK’s first cardio-oncology guidelines. Alongside educational activities, Arjun is involved in research in emerging cardiotoxcities and is also the co-host of the ICOS podcast.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Dent”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Susan Dent, MD
Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff medical oncologist at the Northwestern Ontario Cancer Center in Thunder Bay, Ontario
In 2001, Dr. Dent returned to Ottawa, where she specialized in the treatment of breast cancer. In 2008, Dr. Dent, working with her cardiology colleagues, established a multidisciplinary cardio-oncology clinic in Ottawa; the first of its kind in Canada. In 2011, she founded the Canadian Cardiac Oncology Network (CONN), a not-for-profit organization devoted to optimization of cancer care for patients without compromising cardiovascular health. (www.cardiaconcology.ca). In 2015, Dr. Dent launched the Global Cardio-Oncology Summit (GCOS), an annual meeting which now attracts oncologists, cardiologists, and allied health care providers from more than 23 countries.
Dr. Dent is recognized as a global leader in cardio-oncology. She has travelled
extensively around the world sharing her knowledge and expertise on the potential impact of cancer treatment on cardiovascular health. She has published extensively in the area and has co-authored a number of position statements and clinical practice guidelines. She continues to work and build relationships with global organizations interested in cardio-oncology including: European Society of Cardio-oncology, American College of Cardiology and the American Society of Clinical Oncology. Dr. Dent currently serves as an Executive Officer of the International Cardio-Oncology society (ICOS), an organization dedicated to bringing cardiologists, oncologists, and allied health care providers together, to improve the clinical care of patients and save lives.
In September 2018, Dr. Dent accepted a staff position in medical oncology at Duke
University, where she will continue her efforts in promoting clinical care, education and research in cardio-oncology.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Sebastian”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Sebastian Szmit M.D., Ph.D.
Sebastian Szmit graduated from the Military Medical Academy in Poland. He began cardio-Oncology activities in 2006 working for the Department of Oncology of the Military Institute Of Medicine. He was appointed the executive editor of the Task Force of National Consultants in Cardiology and Clinical Oncology, and developed the first two Polish
Recommendations on cardiovascular safety of patients with breast cancer (published in 2010) and lung cancer (published in 2012).
Since 2012 he has served as the cardio-oncology consultant at the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, at the Centre of Postgraduate Medical Education in Poland. In 2015 he was appointed as the scientific director of the “Oncology in Cardiology” training program. He is the cardio-oncology research coordinator for the Polish Lymphoma Research Group and the Polish National Oncology Network. He co-authored two Educational books: Hypertension-oncology: arterial hypertension in cancer disease and Cardiovascular complications in cancer patients published in 2018 under auspices of the Polish Society of Clinical Oncology.
Since 2019 he has been a Member of the Executive Committee of the Global Cardio-
Oncology Summit (GCOS) and a Member of the Education & Training Advisory Committee of the International Cardio-Oncology Society (ICOS) and in 2020 he was awarded an Honorary Member of the Cardio-Oncology Society of Southern Africa (COSOSA), a Fellow of the International Cardio-Oncology Society (FICOS), and a Board Member of the European Society of Cardiology (ESC) Council of Cardio-Oncology.
On May 26th 2021, Dr. Szmit was asked by the Scientific Council of the Centre of
Postgraduate Medical Education to lead the newly created “Cardiooncology Department and Echocardiography Laboratory” based at the European Health Centre in Otwock (oncology center) and the Institute of Hematology and Transfusion Medicine in Warsaw.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Fradley”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Michael Fradley, MD
Dr. Michael Fradley is an Associate Professor of Clinical Medicine in the Division of Cardiology at the Perelman School of Medicine at the University of Pennsylvania and serves as the medical director of the Penn Medicine Cardio-Oncology program. He earned his B.S at Yale University and his MD degree at the Johns Hopkins University School of Medicine. Dr. Fradley completed his residency in internal medicine through the Osler Medical Residency Program at the Johns Hopkins Hospital. He then went on to complete fellowships in both cardiology and electrophysiology at Massachusetts General Hospital. As a trained electrophysiologist, Dr. Fradley has particular interest in the diagnosis and management of arrhythmic complications associated with traditional and novel cancer therapies. He is a member of the American College of Cardiology Electrophysiology Leadership Council and the IC-OS Board of Directors.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Charles”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Charles Porter, MD
Charles Porter MD established the Cardio-oncology program for the University of Kansas Cancer at the University of Kansas Medical Center in 2007. He was designated as the inaugural American Vice-President of IC-OS in 2009. He has overseen the growth of the KUMC cardio-oncology program and continues to expand its collaboration with a broad array of oncologists in patient care and research. Research includes studies in BMT outcomes, 5FU cardiotoxicity and breast cancer treatment cardiotoxicity. He is associate editor for Cardio-oncology, an editorial consultant for JACC Cardio-oncology, and is a member of the IC-OS Science and Research Committee. He has multiple publications and presentations in the field.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”sahni”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Gagan Sahni MBBS, MD, FACC, FACP, FIC-OS
Dr. Sahni is currently Associate Professor of Medicine and Cardiovascular diseases at Mount Sinai Hospital, New York. She established the first Cardio-Oncology program at Mount Sinai Cardiovascular Institute, where she has been the Director of Cardio- Oncology and Inpatient Cardiology Consult services since 2014. She oversees a robust Cardio-oncology clinic catering to oncology patients from nationwide that are undergoing cancer treatments at Mount Sinai’s Hess Cancer center & provides cardio-oncology consultation to a high volume of inpatient Bone Marrow Transplant and CAR-T patients. She has a special interest in cardiovascular effects of cancer immunotherapy & AL cardiac amyloidosis and has been a clinical teacher–mentor to several students, fellows and cardiologists interested in Cardio-Oncology from the US, Asia & South America.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”joshua”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Joshua Mitchell, MD, MSCI
Joshua Mitchell, MD, MSCI is an Assistant Professor of Medicine and Director of the Cardio-Oncology Fellowship at the Cardio-Oncology Center of Excellence, Washington University School of Medicine in St. Louis. Prior to coming to Washington University in 2015, he served 11 years in the US Army, deploying with the 82nd Airborne Division and the 75th Ranger Regiment, earning two Bronze Start Medals, and reaching the rank of Major. He is currently a member of the ICOS Scientific Committee and recently helped lead the 2021 ICOS expert consensus statement for cardiovascular disease screening in radiation survivors. He also serves on the JACC: Cardio-Oncology editorial board and is the Co-Chair for the ACC Cardio-Oncology working group. His clinical and research interests include better characterizing and understanding cardiovascular disease associated with cancer treatment, and the diagnosis of management of cardiac amyloidosis. His research has also focused on the use of coronary artery calcium to improve risk prediction and help target preventive therapy. As the Cardio-Oncology fellowship director at Washington University in St. Louis, he has directed the training and development for full year fellows, rotations for internal cardiology fellows, and rotations for both external cardiology fellows and for board certified cardiologists looking for additional training in Cardio-Oncology to improve their practice.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”AvirupGuha”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Avirup Guha, MBBS, MPH, FACC, FICOS, RPVI
Dr. Guha is a Director of Cardio-Oncology, Cardio-Oncology Program, Georgia Cancer Center, Assistant Professor of Medicine, Division of Cardiovascular Disease, Augusta University, Augusta, GA, USA. He is an expert in cardiovascular epidemiology pertaining to cardio-oncology. He is the population science principal investigator of one of the American Heart Association’s Strategically Focussed Research Network Grants in Disparities in Cardio-oncology. Additionally, he is a member of the JACC: Cardio-oncology and ICOS So Me working groups.
1410 Laney Walker Blvd, CN 5313
Augusta, GA 30912
Twitter – @avirupguha
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”kapoli”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Dr Kalliopi Keramida (MD, PhD, FESC, FHFA, FICOS)
Dr Kalliopi Keramida (MD, PhD, FESC, FHFA, FICOS) is a consultant cardiologist at General Anti-Cancer, Oncological Hospital Agios Savvas, Athens, Greece. She is board certified in Cardio-Oncology by International Cardio-Oncology Society (ICOS) (2020) and in Heart Failure (ESC/HFA) (2016). Dr Keramida is a member of the Study Group on Cardio-Oncology of HFA and of the Working Group of Cardio-Oncology of the Hellenic Society of Cardiology. Her research interests are focused on cardio-oncology, heart failure and echocardiography. She is member of the editorial board of ESC Heart Failure and Archives of Medical Science and reviewer in several high indexed peer-reviewed journals.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Teresa”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Teresa Lopez-Fernandez, MD
Teresa López-Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain. She is specializes in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. She is the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC) and the Secretary of the ESC Council of Cardio-Oncology.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”kathleenzhang”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Dr. Kathleen Zhang
Dr. Zhang completed medical school and Internal Medicine residency at the University of Pennsylvania, followed by fellowships in Cardiology and Cardio-Oncology at Washington University in St. Louis. She specializes in the cardiovascular care of patients with cancer as well as cardiac amyloidosis at Washington University in St. Louis. She has published over 20 peer-reviewed manuscripts in these areas, and served as an editor for the first edition of The Washington Manual of Cardio-Oncology. She is passionate about improving the diagnosis and treatment of patients with cardiac amyloidosis.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”vijay”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Vijay Rao, MD, PhD
Dr. Rao completed his MD and PhD at the Medical University of South Carolina, Internal Medicine residency at Duke University Medical Center, followed by Cardiology fellowship at the University of California, San Francisco. He is the Director of the CardioOncology, Heart Failure, and Anticoagulation clinics at Franciscan Health in Indianapolis, Indiana. He serves as Chair of the IC-OS Center of Excellence Committee and is an active member of the IC-OS education committee. The Franciscan CardioOncology program won the Association of Community Cancer Centers (ACCC) national Innovator Award in 2019 and was selected as an IC-OS Center of Excellence: Gold Status in 2022. He was also the lead author on a JACC: State of the Art Review on Cardiovascular Toxicity of Oral Antineoplastic Agents in 2021 and is the Governor-Elect of the Indiana Chapter of the American College of Cardiology.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”josephr”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Joseph R. Carver, MD, FACC
Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program. From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients.
He is one of the Founding Editors of Cardio-oncology Journal.
He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient
of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He received the Thomas Force Award in 2020.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”dr_daniel”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Dr. Daniel Cehic
Dr. Daniel Cehic is a cardiologist based in Adelaide, Australia. He trained at the University of Adelaide, Royal Adelaide Hospital and John Radcliffe Hospital in Oxford, England subspecialising in Electrophysiology. He returned to Australia in 1997 and joined Adelaide Cardiology and became a Senior Visiting Cardiologist at the Royal Adelaide Hospital where he remained until 2008, leaving to take up full time private practice with what is now GenesisCare. He became the Chief Medical Officer– Cardiology for GenesisCare in 2017. Daniel has developed an active interest in the field of
CardioOncology and has established CardioOncology clinics in Adelaide and Sydney managing a variety of cardiac complications of cancer therapies and supervising the commencement of similar clinics in other states where GenesisCare has a cardiology presence.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”rosan”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Professor Stuart D Rosen MA MD FRCP FESC FACC FHFA
Professor Stuart Rosen is Consultant Cardiologist at the Royal Brompton and London Northwest Hospitals and Professor of Practice (Cardiology) in the National Heart and Lung Institute, Imperial College and Honorary Adjunct Professor of Cardiovascular Medicine, King’s College, London. He received his medical undergraduate education at Pembroke College, Cambridge and at Charing Cross and Westminster Medical School. His specialist cardiology training was at Charing Cross, Hammersmith and St Mary’s Hospitals and he also spent several years in cardiovascular research, funded by the Medical Research Council and the British Heart Foundation. He is a Fellow of the Royal College of Physicians, American College of Cardiology, European Society of Cardiology (ESC) and the Heart Failure Association of the ESC, as well as a member of its Working Groups on myocardial function and on Cardiovascular Pharmacotherapy. Professor Rosen is also a Fellow of the International Cardio-Oncology Society, a member of the British Cardiovascular Society (BCS), the British Society of Heart Failure and is on the Executive Committee of the Association of Physicians of Great Britain and Ireland.
Professor Rosen is a general adult cardiologist and has specialist expertise in heart failure, syncope, and difficult hypertension. His technical skills include transesophageal echocardiography, stress echo, tilt testing and autonomic assessment, as well as ultrafiltration for decompensated heart failure. Professor Rosen had a pivotal role in setting up the UK’s first cardio-oncology unit, at the Royal Brompton Hospital and in establishing the British Cardio-Oncology Society, of which he is founding Treasurer.
Professor Rosen has a programme of translational research focused on
• Mechanisms of heart injury in cancer patients
• Role of cardiac autonomic dysfunction in pathophysiology of cardiac disease
• Origins of cardiac pain [international task force on complex cardiac pain syndromes]
He is also cardiologist to the MRC’s Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial, a multicentre study of cardiovascular outcomes in prostate cancer patients treated with transcutaneous oestrogen patches compared with LHRH analogues.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”tushar”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Tushar Tarun, MD, FACC, FIC-OS
Dr.Tarun is a non-invasive cardiologist at University of Arkansas for Medical Sciences. His interests include multi-modality cardiac imaging including Echocardiography, Cardiac CT, Cardiac MRI and Nuclear Cardiology. Dr Tarun takes care of cardio-oncology patients from all across the state that visit for their cancer and myeloma care at the renowned cancer center at University of Arkansas for Medical Sciences in Little Rock AR.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Kolluru”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Anuradha Kolluru MD, FACC, FASE, FASNC, RPVI, FICOS
Dr Kolluru is a Board-certified practicing cardiologist with special interests in cardiac imaging and cardio-oncology in USA. She initially started cardio-oncology practice in Decatur, Illinois with large private oncologist group and worked for 8 years before moving to Seattle, Washington in 2020. She is currently working with Virginia Mason Franciscan Health system in Seattle providing cardiovascular care and developing cardio-oncology program.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”modal fade” el_id=”Michelle”][vc_column][vc_row_inner el_class=”modal-dialog”][vc_column_inner el_class=”modal-content”][vc_column_text]
Michelle Weisfelner Bloom, MD
Director, Outpatient Heart Failure and Cardiomyopathy Center
Co-Director, Stony Brook Cardio-Oncology Program
Stony Brook Women’s Heart Center
Stony Brook University Hospital
As the director of the outpatient Heart Failure and Cardiomyopathy Center, Dr. Bloom oversees a large outpatient advanced heart failure practice, receiving complex referrals from local and regional practices throughout Long Island, New York. Her responsibilities include the overseeing of several heart failure nurse practitioners and nurses, and the supervision of an outpatient Heart Failure nurse transition clinic.
Having developed a passion in caring for cancer patients suffering complications of cancer therapies, Dr. Bloom founded the Stony Brook Cardio-Oncology Program in 2015. A first of its kind on Long Island, NY the program remains Suffolk County’s largest such resource. The Stony Brook Cardio-Oncology Program closely observes and cares for cancer patients with, or at-risk of developing cardiac issues before, during and after cancer therapy. The program provides comprehensive imaging and biomarker surveillance, risk stratification, cardiovascular testing, and clinical visits. Dr. Bloom’s program is now part of the regional alliance network with the Memorial Sloan Kettering Cancer Center, and is now the primary source of cardiac referrals from their Commack location.
Dr. Bloom has coauthored several articles on the topic of cancer related cardiac dysfunction, most notably a two-part review series entitled “Cancer Therapy-Related Cardiac Dysfunction and Heart Failure,” in Circulation Heart Failure, in which she collaborated with international experts. Dr. Bloom has spoken regionally, nationally, and internationally as an expert on the topic of cancer therapy related cardiac toxicity and advanced heart failure. She currently serves as the cochair of the writing committee for a Scientific Statement on Cardio-Oncology Care for the Heart Failure Society of America.
Dr. Bloom has been featured on several media outlets including Healthination, “GoodRx,” and News 12 Long Island. She also serves on the advisory boards and speakers bureau for several pharmaceutical companies including Bayer and Astra Zeneca. She has been named a Castle Connolly Top Doctor, “New York Super Doctor” and “Exceptional Women in Medicine” several years in a row.
A passionate teacher, Dr. Bloom serves as a faculty mentor for the “Women to Women Mentoring Program,” through the American Medical Women’s Association, as well as a mentor for trainees from high school and premedical students to fellowship level both clinically and in a research capacity. She serves as the faculty advisor for the medical student-run “Cardiology Interest Group.” She attends on the inpatient CCU and step-down cardiac unit, as well as the inpatient heart failure consult and ventricular assist device service regularly.
Dr. Bloom received her medical degree at The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, and went on to complete her Internal Medicine residency at Montefiore Medical Center, Bronx, NY. She completed both her General Cardiology and Advanced Heart Failure and Transplant Fellowship at the Mount Sinai Medical Center in New York, NY.
Dr. Michelle Bloom is the proud mother of three boys who take up all the remainder of her “free time”.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]
